Page last updated: 2024-11-07

iminodisuccinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

iminodisuccinic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID131409
SCHEMBL ID22019
MeSH IDM0369054

Synonyms (21)

Synonym
iminodisuccinate
131669-35-7
iminodisuccinic acid
d-aspartic acid,n-[(1s)-1,2-dicarboxyethyl]-, rel-
7408-20-0
SCHEMBL22019
n-(1,2-dicarboxyethyl)-dl-aspartic acid
BJZ451DI42 ,
70543-06-5
dl-aspartic acid, n-(1,2-dicarboxyethyl)-
iminodisuccinic acid [mi]
PQHYOGIRXOKOEJ-UHFFFAOYSA-N
2,2'-iminodisuccinic acid
imidodisuccinic acid
unii-bjz451di42
AKOS030524279
2,2'-azanediyldisuccinic acid
Q27274711
2-(1,2-dicarboxyethylamino)butanedioic acid
DTXSID00861375
2,2'-azanediyldibutanedioic acid (non-preferred name)

Research Excerpts

Overview

Iminodisuccinic acid (IDHA) is a biodegradable chelating agent that is currently being evaluated as an alternative to EDTA.

ExcerptReferenceRelevance
"Iminodisuccinic acid (IDHA) is a biodegradable chelating agent that is currently being evaluated as an alternative to EDTA."( Iron supply to soybean plants through the foliar application of IDHA/Fe3+: effect of plant nutritional status and adjuvants.
Hernández-Apaolaza, L; Lucena, JJ; Rodríguez-Lucena, P; Ropero, E, 2010
)
1.08

Bioavailability

ExcerptReferenceRelevance
" This study reports HIDS for the first time as a promising chelating ligand for the enhancement of Fe bioavailability and As phytoextraction."( Hydroxyiminodisuccinic acid (HIDS): A novel biodegradable chelating ligand for the increase of iron bioavailability and arsenic phytoextraction.
Hasegawa, H; Kadohashi, K; Maki, T; Rahman, MA; Ueda, K, 2009
)
0.81
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (50.00)29.6817
2010's5 (35.71)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.23 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.32 (4.65)
Search Engine Demand Index31.18 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]